Clinical Trial Update: Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial of the Venezuelan Equine Encephalitis attenuated live-virus vaccine was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venezuelan Equine Encephalitis

Drugs mentioned

• VEE Attenuated Live-Virus Vaccine (Venezuelan equine encephalitis attenuated live-virus vaccine)

Snippet

Sponsor: DynPort Vaccine Company LLC, A GDIT Company | Conditions: Venezuelan Equine Encephalitis | Phase 1 | Status: WITHDRAWN